Chapter 8. Semi-Solid Dosage CDMO Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Mexico Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5. Europe
8.5.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. UK Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Germany Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. France Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Italy Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Spain Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.7. Sweden
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Sweden Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.8. Denmark
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Denmark Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Norway Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6. Asia Pacific
8.6.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Japan Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. China Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. India Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6.5. Thailand
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Thailand Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. South Korea Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.6.7. Australia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Australia Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.7. Latin America
8.7.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Brazil Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.8. MEA
8.8.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. South Africa Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Saudi Arabia Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. UAE Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Kuwait Semi-Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 4 Global Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 5 Global Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 6 Global Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 7 Global Semi-Solid Dosage CDMO, by Region, 2018 - 2030 (USD Million)
Table 8 North America Semi-Solid Dosage CDMO, by Country, 2018 - 2030 (USD Million)
Table 9 North America Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 10 North America Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 11 North America Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 12 North America Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 13 U.S. Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 14 U.S. Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 15 U.S. Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 16 U.S. Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 17 Canada Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 18 Canada Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 19 Canada Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 20 Canada Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 21 Mexico Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 22 Mexico Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 23 Mexico Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 24 Mexico Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 25 Europe Semi-Solid Dosage CDMO, by Country, 2018 - 2030 (USD Million)
Table 26 Europe Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 27 Europe Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 28 Europe Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 29 Europe Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 30 UK Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 31 UK Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 32 UK Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 33 UK Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 34 Germany Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 36 Germany Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 37 Germany Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 38 France Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 39 France Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 40 France Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 41 France Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 42 Italy Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 43 Italy Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 44 Italy Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 45 Italy Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 46 Spain Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 47 Spain Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 48 Spain Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 49 Spain Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 50 Denmark Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 51 Denmark Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 52 Denmark Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 53 Denmark Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 54 Sweden Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 55 Sweden Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 56 Sweden Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 57 Sweden Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 58 Norway Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 59 Norway Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 60 Norway Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 61 Norway Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Semi-Solid Dosage CDMO, by Country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 67 Japan Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 68 Japan Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 69 Japan Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 70 Japan Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 71 China Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 72 China Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 73 China Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 74 China Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 75 India Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 76 India Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 77 India Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 78 India Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 79 Thailand Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 80 Thailand Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 81 Thailand Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 82 Thailand Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 83 South Korea Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 84 South Korea Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 85 South Korea Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 86 South Korea Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 87 Australia Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 88 Australia Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 89 Australia Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 90 Australia Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 91 Latin America Semi-Solid Dosage CDMO, by Country, 2018 - 2030 (USD Million)
Table 92 Latin America Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 93 Latin America Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 94 Latin America Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 95 Latin America Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 96 Brazil Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 97 Brazil Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 98 Brazil Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 99 Brazil Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 100 Argentina Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 101 Argentina Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 102 Argentina Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 103 Argentina Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Semi-Solid Dosage CDMO, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 109 South Africa Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 110 South Africa Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 111 South Africa Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 112 South Africa Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 117 UAE Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 118 UAE Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 119 UAE Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 120 UAE Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
Table 121 Kuwait Semi-Solid Dosage CDMO, by Route of Administration, 2018 - 2030 (USD Million)
Table 122 Kuwait Semi-Solid Dosage CDMO, by Product, 2018 - 2030 (USD Million)
Table 123 Kuwait Semi-Solid Dosage CDMO, by Service, 2018 - 2030 (USD Million)
Table 124 Kuwait Semi-Solid Dosage CDMO, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Semi-Solid Dosage CDMO Market revenue, 2018 - 2030 (USD Million)
Fig. 10 Semi-Solid Dosage CDMO Market snapshot
Fig. 11 Semi-Solid Dosage CDMO Market driver impact
Fig. 12 Semi-Solid Dosage CDMO Market restraint impact
Fig. 13 Semi-Solid Dosage CDMO sector Route of administration takeaways (USD Million)
Fig. 14 Semi-Solid Dosage CDMO Market: Route of administration movement analysis
Fig. 15 Topical market, 2018 - 2030 (USD Million)
Fig. 16 Transdermal market, 2018 - 2030 (USD Million)
Fig. 17 Others market, 2018 - 2030 (USD Million)
Fig. 18 Semi-Solid Dosage CDMO sector Product takeaways (USD Million)
Fig. 19 Semi-Solid Dosage CDMO Market: Product movement analysis
Fig. 20 Ointments market, 2018 - 2030 (USD Million)
Fig. 21 Creams and Lotions market, 2018 - 2030 (USD Million)
Fig. 22 Pastes market, 2018 - 2030 (USD Million)
Fig. 23 Gels market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Semi-Solid Dosage CDMO sector Service takeaways (USD Million)
Fig. 26 Semi-Solid Dosage CDMO Market: Service movement analysis
Fig. 27 Contract Development market, 2018 - 2030 (USD Million)
Fig. 28 Contract Manufacturing market, 2018 - 2030 (USD Million)
Fig. 29 Semi-Solid Dosage CDMO sector End Use takeaways (USD Million)
Fig. 30 Semi-Solid Dosage CDMO Market: End Use movement analysis
Fig. 31 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 32 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 Regional outlook, 2024 & 2030
Fig. 36 North America Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 37 U.S. Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 39 Mexico Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 40 Europe Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 41 UK Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 42 Germany Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 43 France Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 44 Italy Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 45 Spain companion animal Health market, 2018 - 2030 (USD Million)
Fig. 46 Sweden Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 47 Denmark Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 48 Norway Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 50 Japan Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 51 China Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 52 India Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 54 South Korea Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 55 Australia Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 56 Latin America Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 57 Brazil Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 58 Argentina Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 59 Middle East & Africa Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 60 South Africa Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 62 UAE Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 63 Kuwait Semi-Solid Dosage CDMO Market, 2018 - 2030 (USD Million)
Fig. 64 Market participant categorization